Rik Saylor Financial’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,500
Closed -$2.84K 91
2026
Q1
$2.84K Buy
+11,500
New +$4.58K ﹤0.01% 85

Other funds holding SGMO

Rik Saylor Financial's SGMO Position: Q2 2026 in Review

Rik Saylor Financial sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 11,500 shares — an estimated $2.84K sold.

Rik Saylor Financial first reported a position in SGMO in Q1 2026 and held it in 1 quarter. The position peaked at $2.84K in Q1 2026. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

  • Rik Saylor Financial reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
  • Rik Saylor Financial sold 11,500 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $2.84K.
  • Rik Saylor Financial first reported a position in SANGAMO THERAPEUTICS INC in Q1 2026 and held it in 1 quarter.
  • Rik Saylor Financial's SANGAMO THERAPEUTICS INC position peaked at $2.84K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Rik Saylor Financial's 13F filing for Q2 2026, filed 5 Aug 2026.